Loading…

Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19

The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of t...

Full description

Saved in:
Bibliographic Details
Published in:iScience 2021-03, Vol.24 (3), p.102135-102135, Article 102135
Main Authors: Bankar, Renuka, Suvarna, Kruthi, Ghantasala, Saicharan, Banerjee, Arghya, Biswas, Deeptarup, Choudhury, Manisha, Palanivel, Viswanthram, Salkar, Akanksha, Verma, Ayushi, Singh, Avinash, Mukherjee, Amrita, Pai, Medha Gayathri J., Roy, Jyotirmoy, Srivastava, Alisha, Badaya, Apoorva, Agrawal, Sachee, Shrivastav, Om, Shastri, Jayanthi, Srivastava, Sanjeeva
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of the host proteins such as interleukin-6, L-lactate dehydrogenase, C-reactive protein, Ferritin, and aspartate aminotransferase were found to be upregulated only in COVID-19-positive patients using targeted multiple reaction monitoring studies. The most important pathways identified by enrichment analysis were neutrophil degranulation, interleukin-12 signaling pathways, and mRNA translation of proteins thus providing the detailed investigation of host response in COVID-19 infection. Thus, we conclude that mass spectrometry-detected host proteins have a potential for disease severity progression; however, suitable validation strategies should be deployed for the clinical translation. Furthermore, the in silico docking of potential drugs with host proteins involved in the interleukin-12 signaling pathway might aid in COVID-19 therapeutic interventions. [Display omitted] •High-resolution mass spectrometry of swab identified 164 significant host proteins•Upregulation of LDH, Ferritin, and AST was validated by MRM assays•Significant alteration of immune response and translational pathways was observed•In silico docking identified Loratadine binding to interleukin signaling proteins Specimen; molecular biology; proteomics
ISSN:2589-0042
2589-0042
DOI:10.1016/j.isci.2021.102135